This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Swart, R. L. Articles by Osterhaus, A. D. M. E. Search for Related Content PubMed PubMed Citation Articles by de Swart, R. L. Articles by Osterhaus, A. D. M. E.

 Previous Article  |  Next Article 

Journal of Virology, September 2005, p. 11547-11551, Vol. 79, No. 17
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.17.11547-11551.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Relative Contributions of Measles Virus Hemagglutinin- and Fusion Protein-Specific Serum Antibodies to Virus Neutralization

Department of Virology, Erasmus MC, Rotterdam, The Netherlands

Received 15 April 2005/ Accepted 7 June 2005

The relative contribution of measles virus hemagglutinin (H)- or fusion protein (F)-specific antibodies to virus neutralization (VN) has not been demonstrated. We have depleted these specific antibodies from sera collected from young adults, who had been vaccinated during childhood, by prolonged incubation with viable transfected human melanoma cells expressing H or F. Simultaneous depletion of antibodies of both specificities completely abrogated VN activity. Depletion of F-specific antibodies only had a minimal effect, whereas removal of H-specific antibodies resulted in almost complete reduction of VN activity. These results demonstrate that measles virus neutralizing antibodies are mainly directed to the H protein.

This article has been cited by other articles:

• Pan, C.-H., Nair, N., Adams, R. J., Zink, M. C., Lee, E.-Y., Polack, F. P., Singh, M., O'Hagan, D. T., Griffin, D. E. (2008). Dose-Dependent Protection against or Exacerbation of Disease by a Polylactide Glycolide Microparticle-Adsorbed, Alphavirus-Based Measles Virus DNA Vaccine in Rhesus Macaques. CVI 15: 697-706 [Abstract] [Full Text]  
• Hashiguchi, T., Kajikawa, M., Maita, N., Takeda, M., Kuroki, K., Sasaki, K., Kohda, D., Yanagi, Y., Maenaka, K. (2007). Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc. Natl. Acad. Sci. USA 104: 19535-19540 [Abstract] [Full Text]  
• Weingartl, H. M., Berhane, Y., Caswell, J. L., Loosmore, S., Audonnet, J.-C., Roth, J. A., Czub, M. (2006). Recombinant Nipah Virus Vaccines Protect Pigs against Challenge.. J. Virol. 80: 7929-7938 [Abstract] [Full Text]  
• Capozzo, A. V. E., Ramirez, K., Polo, J. M., Ulmer, J., Barry, E. M., Levine, M. M., Pasetti, M. F. (2006). Neonatal Immunization with a Sindbis Virus-DNA Measles Vaccine Induces Adult-Like Neutralizing Antibodies and Cell-Mediated Immunity in the Presence of Maternal Antibodies. J. Immunol. 176: 5671-5681 [Abstract] [Full Text]